SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMMUNE NETWORK RESEARCH (VSE:IMM)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: IKE who wrote (74)10/20/1998 11:04:00 PM
From: John Fairchild  Read Replies (2) of 134
 
From Jase posted on Stockhouse IMM forum Oct 18.

I contacted IMM through their e-mail address looking for some general information. Marc Hoelscher responded and this is what he had to say; "The recent interest comes as a result of INR confirming that the Phase II mAb1F7 testing had been completed successfully and that a report was in the process of being put together to confirm viral loads etc..." He said that the two scientiests, Mueller and Kohler have been in Europe for a couple of weeks and that upon their return the report would be completed! He felt that the report announcing the viral loads would not be out until sometime in November. Looks we will have to wait just a little bit longer than originally thought for this information.

=====================================================

John
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext